Periodontal disease and visfatin level: A systematic review and meta-analysis

Visfatin is considered an inflammatory biomarker in periodontal disease (PD). In this meta-analysis, we aimed to evaluate the relationship between Visfatin biomarker level with PD. In this study, Medline, Scopus, Web of Science, and Google Scholar were searched. We included studies that examined vis...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2023-11, Vol.18 (11), p.e0293368-e0293368
Main Authors: Bayani, Mojtaba, Heidari, MohammadTaha, Almasi-Hashiani, Amir
Format: Article
Language:English
Subjects:
B cells
Biology and Life Sciences
Biomarkers
Care and treatment
Cytokines
Diagnosis
Evaluation
Full text
Gingivitis
Gum disease
Health aspects
Heterogeneity
Medicine and Health Sciences
Meta-analysis
Periodontal disease
Periodontal diseases
Periodontitis
Physical Sciences
Research and Analysis Methods
Saliva
Software
Systematic review
Type 2 diabetes
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Visfatin is considered an inflammatory biomarker in periodontal disease (PD). In this meta-analysis, we aimed to evaluate the relationship between Visfatin biomarker level with PD. In this study, Medline, Scopus, Web of Science, and Google Scholar were searched. We included studies that examined visfatin levels in samples from healthy people and periodontal disease until March 2023. The quality of the selected articles was evaluated using the Newcastle-Ottawa assessment scale. Depending on heterogeneity of studies, random-effects or fixed-effect models were used to pool results and report the standardized mean difference (SMD). After screening the retrieved papers, the related data were extracted. A total of 159 studies were identified, and 16 studies were included in the meta-analysis. In 9 studies, the SMD of visfatin level of gingival crevicular fluid (GCF) in patients with chronic periodontitis (CP) and healthy individuals was 4.32 (p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0293368